Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19
José F. Varona(Hospital Universitario HM Madrid), José Jimeno(European Organisation for Research and Treatment of Cancer), Jesús Fortün(Evidence (Italy)), Nuria Izquierdo‐Useros(IrsiCaixa), Pedro Landete(Hospital Universitario de La Princesa), Kirsten Obernier(QB3), Isabel Sola(Centro Nacional de Biotecnología), María José Pontes(Instituto Vita), Nevan J. Krogan(QB3), Lucy Thorne(University College London), Bonaventura Clotet(Universitat de Vic - Universitat Central de Catalunya), Lorena Zuliani‐Alvarez(Gladstone Institutes), Belén Sopesén(PharmaMar (Spain)), Alvaro Belgrano(PharmaMar (Spain)), Salvador Fudio(PharmaMar (Spain)), Daniel Carnevali(Hospital Universitario Quirónsalud Madrid), Rubin Lubomirov(PharmaMar (Spain)), Kris M. White(Icahn School of Medicine at Mount Sinai), Lucía Fernández de Orueta(Hospital Universitario de Getafe), Paloma Gijón(Hospital General Universitario Gregorio Marañón), Antonio Martínez Nieto(PharmaMar (Spain)), Daniel Abad(Hospital Universitario de Getafe), Noemí Cabello(Hospital Clínico San Carlos), Roberto Vates(Hospital Universitario de Getafe), Mehdi Bouhaddou(QB3), Sonia Zúñiga(Centro Nacional de Biotecnología), José Barberán(Universidad San Pablo CEU), Pablo Guisado‐Vasco(Hospital Universitario Quirónsalud Madrid), Greg J. Towers(University College London), Romel Rosales(Icahn School of Medicine at Mount Sinai), Luis Enjuanes(Centro Nacional de Biotecnología), A Monereo(Hospital Universitario de Getafe), Myosotys Rodriguez(Florida International University), Ann‐Kathrin Reuschl(University College London), Javier Gómez(John H. Stroger, Jr. Hospital of Cook County), Pablo Avilés(PharmaMar (Spain)), Patricia Girón de Velasco(PharmaMar (Spain)), Julio Ancochea(Hospital Universitario de La Princesa), Júlia Vergara‐Alert(Animal Health Research Institute), Miguel Torralba(Universidad de Alcalá), José A. López-Martín(Research Institute Hospital 12 de Octubre), Clare Jolly(Institute of Infection and Immunity), Soner Yildiz(Icahn School of Medicine at Mount Sinai), Roger Paredes(Hospital Universitari Germans Trias i Pujol), Jordi Rodon(Centre de Recerca en Sanitat Animal), Beatriz de Rivas(PharmaMar (Spain)), Jose M Fernandez-Sousa(PharmaMar (Spain)), Vicente Estrada(Instituto de Salud Carlos III), Lourdes Porras(Hospital General Universitario de Ciudad Real), Briana L McGovern(Icahn School of Medicine at Mount Sinai)
Cited by 52
Related Papers
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
|Clinical Microbiology and Infection|2018|1.5k
Commentary: Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group
|Journal of Virology|2013|1.3k
The Global Phosphorylation Landscape of SARS-CoV-2 Infection
|Cell|2020|1.2k